Access cutting-edge covid-19 treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible participants will be randomly assigned (by chance) to receive ibuzatrelvir or matching placebo orally for 5 days. Co-administration of locally available standard of care is allowed. The total duration of the study is around 6 months.
Sponsor: Pfizer
Check if you qualify for this covid-19 clinical trial in Little Rock, AR
If you're searching for covid-19 treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.